Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
ZBHZimmer Biomet
FinDog View：Neutral
| Metric | LLY | ZBH |
|---|
| Close | 1,137.82 | 96.78 |
| Market Cap | $1.07T | $18.4B |
| 1M | −3.83% | −1.45% |
| P/E (TTM) | 39.9 | 22.1 |
| Forward P/E | 28.5 | 10.8 |
| P/E 5-Yr Percentile | 6 | 25 |
| P/S | 13.4 | 2.1 |
| P/B | 31.5 | 1.4 |
| Dividend Yield | 0.75% | 1.04% |
| Latest Quarter Revenue | $23.0B | $2.2B |
| Revenue YoY | +47.7% | +4.8% |
| Gross Margin | 85.8% | 70.8% |
| Latest Quarter EPS | 7.94 | 1.03 |
| Avg Post-Earnings Move | ±3.5% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.12% | 5.11% |
| 90-Day Net Insider Buying | −$16.0M | −$0.82M |
LLY · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
